###begin article-title 0
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 128 132 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 24 53 <span type="species:ncbi:87786">human endogenous retrovirus W</span>
Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 84 92 <span type="species:ncbi:9606">patients</span>
###xml 156 183 <span type="species:ncbi:11827">human endogenous retrovirus</span>
Multiple sclerosis-associated retrovirus (MSRV) RNA sequences have been detected in patients with multiple sclerosis (MS) and are related to the multi-copy human endogenous retrovirus family type W (HERV-W). Only one HERV-W locus (ERVWE1) codes for a complete HERV-W Env protein (Syncytin-1). Syncytin-1 and the putative MSRV Env protein have been involved in the pathogenesis of MS. The origin of MSRV and its precise relation to HERV-W were hitherto unknown.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 212 216 212 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 301 305 301 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 415 419 415 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 474 483 474 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 525 529 525 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 569 573 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 661 665 661 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 722 726 722 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 875 879 875 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
###xml 351 359 <span type="species:ncbi:9606">patients</span>
By mapping HERV-W env cDNA sequences (n = 332) from peripheral blood mononuclear cells of patients with MS and healthy controls onto individual genomic HERV-W env elements, we identified seven transcribed HERV-W env loci in these cells, including ERVWE1. Transcriptional activity of individual HERV-W env elements did not significantly differ between patients with MS and controls. Remarkably, almost 30% of HERV-W env cDNAs were recombined sequences that most likely arose in vitro between transcripts from different HERV-W env elements. Re-analysis of published MSRV env sequences revealed that all of them can be explained as originating from genomic HERV-W env loci or recombinations among them. In particular, a MSRV env clone previously used for the generation of monoclonal antibody 6A2B2, detecting an antigen in MS brain lesions, appears to be derived from a HERV-W env locus on chromosome Xq22.3. This locus harbors a long open reading frame for an N-terminally truncated HERV-W Env protein.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 163 167 163 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
Our data clarify the origin of MSRV env sequences, have important implications for the status of MSRV, and open the possibility that a protein encoded by a HERV-W env element on chromosome Xq22.3 may be expressed in MS brain lesions.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 215 216 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 440 441 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 649 650 649 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 651 652 651 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 812 813 812 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 814 815 814 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1007 1008 1007 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1224 1225 1224 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1226 1228 1226 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1288 1291 1288 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag</italic>
###xml 1293 1296 1293 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pro</italic>
###xml 1298 1301 1298 1301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pol</italic>
###xml 1307 1311 1307 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1450 1452 1450 1452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1634 1636 1634 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1933 1935 1933 1935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1936 1938 1936 1938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 2019 2020 2019 2020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 2021 2023 2021 2023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 2047 2051 2047 2051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 2200 2202 2200 2202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 2356 2358 2356 2358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 2425 2435 2425 2435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bona fide </italic>
###xml 2447 2449 2447 2449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 250 284 <span type="species:ncbi:11908">human T cell leukemia virus type 1</span>
###xml 297 302 <span type="species:ncbi:9606">human</span>
###xml 631 639 <span type="species:ncbi:9606">patients</span>
###xml 840 845 <span type="species:ncbi:9606">human</span>
###xml 948 975 <span type="species:ncbi:11827">human endogenous retrovirus</span>
###xml 977 981 <span type="species:ncbi:11827">HERV</span>
###xml 998 1002 <span type="species:ncbi:11827">HERV</span>
###xml 1153 1159 <span type="species:ncbi:9606">humans</span>
###xml 1362 1366 <span type="species:ncbi:11827">HERV</span>
###xml 1436 1441 <span type="species:ncbi:9606">human</span>
###xml 1655 1659 <span type="species:ncbi:11827">HERV</span>
###xml 1670 1674 <span type="species:ncbi:11827">HERV</span>
###xml 1802 1806 <span type="species:ncbi:11827">HERV</span>
###xml 1975 1979 <span type="species:ncbi:11827">HERV</span>
###xml 2040 2044 <span type="species:ncbi:11827">HERV</span>
###xml 2435 2440 <span type="species:ncbi:9606">human</span>
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system thought to result from an as yet incompletely understood complex interplay of genetic and environmental factors [1]. Stimulated by the finding that human T cell leukemia virus type 1 (HTLV-1), a human exogenous retrovirus, causes a neurological disease (HTLV-1 associated myelopathy/tropical spastic paraparesis) with similarities to MS [2], retroviruses have also been searched for in MS. This led to the detection of retrovirus-like particles containing reverse transcriptase activity in the supernatants from cultured cell of patients with MS [3-5]. After molecular characterization of retroviral RNA sequences within such particles, this novel retroviral element was named MS-associated retrovirus (MSRV) [6,7]. Subsequent probing of human genomic DNA with MSRV sequences revealed endogenous retroviral sequences closely related to MSRV, the human endogenous retrovirus (HERV) family type W (HERV-W) [8]. HERVs are remnants of ancestral germ line infections by active retroviruses, which have thereafter been transmitted in a Mendelian manner. In humans, HERVs comprise approximately 8% of the genome (for review see [9,10]). They typically consist of an internal region containing gag, pro, pol, and env genes, flanked by two long terminal repeats (LTR). HERV-W is a multicopy family consisting of ~650 elements dispersed in the human genome [11]. About 280 of those elements contain internal sequences. The remaining elements lack internal regions because of recombinational deletion between the two LTRs, leaving a solo LTR [11]. Like almost all HERV families, HERV-W is highly defective due to acquisition of stop-codons, frameshift mutations, and deletions. In addition, many members of the HERV-W family represent processed pseudogenes that were generated through retrotransposition by long interspersed elements (LINE) [11-13]. Notably, no replication-competent HERV-W provirus could be identified so far [8,14]. Yet, a single HERV-W env locus (ERVWE1, chromosomal location 7q21.2) retained a complete open reading frame (ORF) for a functional envelope (Env) protein, termed Syncytin-1 [15]. Syncytin-1 is highly expressed in the placenta where it likely participates in the fusion of cytotrophoblast cells into the syncytiotrophoblast layer [16]. The ERVWE1 locus therefore appears to have been diverted into a bona fide human gene [17].
###end p 9
###begin p 10
###xml 217 220 217 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env</italic>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 736 744 736 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 822 830 822 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 181 185 <span type="species:ncbi:11827">HERV</span>
###xml 210 214 <span type="species:ncbi:11827">HERV</span>
###xml 298 306 <span type="species:ncbi:9606">patients</span>
###xml 425 429 <span type="species:ncbi:11827">HERV</span>
###xml 528 536 <span type="species:ncbi:9606">patients</span>
###xml 596 600 <span type="species:ncbi:11827">HERV</span>
###xml 783 789 <span type="species:ncbi:10090">murine</span>
Intriguingly, in addition to the physiological function of Syncytin-1 in placental morphogenesis, several studies have provided evidence in support of a possible pathogenic role of HERV-W Env/Syncytin-1 in MS. HERV-W env/Syncytin-1 RNA levels were found to be higher in autopsied brain tissue from patients with MS than in brain tissue from controls [18-21]. Neuropathological investigations reported increased expression of HERV-W Env/Syncytin-1 protein in astrocytes and microglia in actively demyelinating brain lesions from patients with MS [18,21,22]. A potential pathogenic significance of HERV-W Env/Syncytin-1 expression in MS can be inferred from data showing that Syncytin-1 has indirect cytotoxic effects on oligodendrocytes in vitro, and that expression of Syncytin-1 in murine models results in demyelination in vivo [18,22].
###end p 10
###begin p 11
###xml 53 54 53 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 680 682 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 849 851 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 244 249 <span type="species:ncbi:9606">human</span>
###xml 340 345 <span type="species:ncbi:9606">human</span>
###xml 599 607 <span type="species:ncbi:9606">patients</span>
A putative MSRV Env protein was previously reported [7,23]. The surface (SU) domain of MSRV Env (AF331500), the amino acid sequence of which is 87% identical to Syncytin-1, has been shown to stimulate production of proinflammatory cytokines in human monocytes via engagement of CD14 and toll-like receptor 4. It also triggers maturation of human dendritic cells and confers on them the potential to polarize naive T-cells into Th-1-like effector T-lymphocytes [24]. Production of IFN-gamma, IL-6, and IL-12p40 following stimulation with MSRV Env SU of peripheral blood mononuclear cells (PBMC) from patients with MS is significantly higher compared to PBMC from healthy controls [25]. In addition, MSRV Env induces a polyclonal activation of T-cells bearing specific Vbeta chains, reminiscent of immunopathogenic effects triggered by superantigens [23]. Altogether, those proinflammatory properties of MSRV Env appear compatible with a potential relevance of MSRV Env in the context of MS, too.
###end p 11
###begin p 12
###xml 348 349 348 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 350 351 350 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 687 689 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 811 813 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 814 816 814 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 38 42 <span type="species:ncbi:11827">HERV</span>
###xml 136 140 <span type="species:ncbi:11827">HERV</span>
###xml 330 338 <span type="species:ncbi:9606">patients</span>
###xml 420 424 <span type="species:ncbi:11827">HERV</span>
###xml 443 447 <span type="species:ncbi:11827">HERV</span>
###xml 777 781 <span type="species:ncbi:11827">HERV</span>
Despite the possible role of MSRV and HERV-W (Syncytin-1) in MS, the exact origin of MSRV and the precise relationship between MSRV and HERV-W have been hitherto unclear. MSRV has been defined by different overlapping cDNA clones that were generated from particle-associated RNA from plasma or supernatants of cultured cells from patients with MS [6,7,23]. Sequences of those cloned cDNAs were reported to be similar to HERV-W, but individual HERV-W proviruses from which those sequences may have originated could not be identified so far. To date, there exists no molecular clone containing a complete infectious MSRV genome, and the very nature of MSRV has thus remained uncertain [26,27]. This has further stimulated a discussion over the relative contributions of MSRV and HERV-W to the pathogenesis of MS [20,28-30].
###end p 12
###begin p 13
###xml 280 281 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 974 978 974 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1004 1008 1004 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1065 1066 1065 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1067 1069 1067 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1165 1169 1165 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1224 1226 1224 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1227 1229 1227 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 64 91 <span type="species:ncbi:11746">Jaagsiekte sheep retrovirus</span>
###xml 261 266 <span type="species:ncbi:9606">human</span>
###xml 532 536 <span type="species:ncbi:11827">HERV</span>
###xml 559 564 <span type="species:ncbi:9606">human</span>
###xml 676 680 <span type="species:ncbi:11827">HERV</span>
###xml 720 725 <span type="species:ncbi:9606">human</span>
###xml 846 854 <span type="species:ncbi:9606">patients</span>
###xml 908 912 <span type="species:ncbi:11827">HERV</span>
###xml 967 971 <span type="species:ncbi:11827">HERV</span>
###xml 1047 1055 <span type="species:ncbi:9606">patients</span>
###xml 1158 1162 <span type="species:ncbi:11827">HERV</span>
###xml 1212 1217 <span type="species:ncbi:9606">human</span>
By analogy to some well-characterized animal retroviruses (e.g. Jaagsiekte sheep retrovirus), it has been speculated that MSRV could be an exogenous member of an endogenous retrovirus family which consequently might be able to form novel proviral insertions in human genomic DNA [6,30-32]. If this was the case, it may be assumed that RNA transcripts from such proviral MSRV insertions are specifically detectable in individuals infected with MSRV. However, complicating the identification of such MSRV RNA transcripts, many of the HERV-W elements present in human genomic DNA, which all are very similar to MSRV, may produce RNA transcripts as well. We therefore asked which HERV-W loci are transcriptionally active in human cells, and whether transcripts corresponding to previously published MSRV sequences might be specifically detectable in patients with MS. Given the potential pathogenic role of MSRV/HERV-W Env proteins in MS, we focused our analysis on MSRV/HERV-W env sequences. Published MSRV env sequences were obtained from plasma of patients with MS [7,23]. Since MSRV sequences found in plasma are likely to originate from PBMC and since MSRV/HERV-W env sequences have previously been detected in human PBMC [18-21] we chose to analyze PBMC in this work.
###end p 13
###begin p 14
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 169 173 169 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 255 263 255 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 320 324 320 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 328 332 328 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag </italic>
###xml 45 49 <span type="species:ncbi:11827">HERV</span>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
###xml 162 166 <span type="species:ncbi:11827">HERV</span>
###xml 390 394 <span type="species:ncbi:11827">HERV</span>
###xml 620 624 <span type="species:ncbi:11827">HERV</span>
Herein, we identify transcriptionally active HERV-W env loci in PBMC from patients with MS and healthy controls. We also demonstrate that analysis of transcribed HERV-W env elements is complicated by frequent recombinations that are most likely generated in vitro. Based on these results we show that the published MSRV env and gag sequences can be explained as originating from endogenous HERV-W loci or recombinations among them. By clarifying the origin of MSRV sequences, our data help to settle a longstanding debate, and have important implications for the status of MSRV as well as for the potential role of MSRV/HERV-W Env in the pathogenesis of MS.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
###xml 25 29 <span type="species:ncbi:11827">HERV</span>
###xml 44 49 <span type="species:ncbi:9606">human</span>
Transcriptionally active HERV-W env loci in human PBMC
###end title 16
###begin p 17
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 288 292 288 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 309 313 309 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 604 605 604 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 637 640 637 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env</italic>
###xml 694 698 694 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 780 783 780 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env</italic>
###xml 859 863 859 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 896 900 896 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1005 1009 1005 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1132 1136 1132 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1216 1220 1216 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1258 1262 1258 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1479 1483 1479 1483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1531 1535 1531 1535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1623 1627 1623 1627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1649 1650 1649 1650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 95 99 <span type="species:ncbi:11827">HERV</span>
###xml 108 113 <span type="species:ncbi:9606">human</span>
###xml 194 200 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 281 285 <span type="species:ncbi:11827">HERV</span>
###xml 336 344 <span type="species:ncbi:9606">patients</span>
###xml 445 453 <span type="species:ncbi:9606">patients</span>
###xml 630 634 <span type="species:ncbi:11827">HERV</span>
###xml 687 691 <span type="species:ncbi:11827">HERV</span>
###xml 773 777 <span type="species:ncbi:11827">HERV</span>
###xml 889 893 <span type="species:ncbi:11827">HERV</span>
###xml 998 1002 <span type="species:ncbi:11827">HERV</span>
###xml 1021 1026 <span type="species:ncbi:9606">human</span>
###xml 1125 1129 <span type="species:ncbi:11827">HERV</span>
###xml 1165 1170 <span type="species:ncbi:9606">human</span>
###xml 1209 1213 <span type="species:ncbi:11827">HERV</span>
###xml 1251 1255 <span type="species:ncbi:11827">HERV</span>
###xml 1472 1476 <span type="species:ncbi:11827">HERV</span>
###xml 1524 1528 <span type="species:ncbi:11827">HERV</span>
###xml 1547 1552 <span type="species:ncbi:9606">human</span>
###xml 1616 1620 <span type="species:ncbi:11827">HERV</span>
We previously described an experimental strategy to identify distinct transcriptionally active HERV loci in human tissues and cells, which we applied to detect transcribed proviral loci for the HERV-K(HML-2) family [33-35]. Using this strategy, we aimed at identifying transcribed HERV-W env loci and/or MSRV env sequences in PBMC from patients with MS and healthy controls. To this end, we performed RT-PCR on total RNA isolated from PBMC of 4 patients with MS and 4 healthy controls. An extensive DNAse digestion protocol assured the absence of contaminating genomic DNA in all samples studied (Figure 1). We employed a pair of HERV-W env-specific PCR primers located in the region of HERV-W env coding for the SU domain and generating a PCR product of about 640 bp. The HERV-W env-specific PCR primers were designed to amplify the previously reported MSRV env sequence AF331500 and the HERV-W env locus on chromosome 7q21.2 (ERVWE1). In addition, they potentially recognize at least eight other HERV-W env loci in the human genome, as determined by BLAT PCR analyses . However, according to more detailed comparisons with HERV-W env sequences retrieved from the human genome sequence, the actual number of HERV-W env loci possibly amplified by the HERV-W env primers is probably even higher, since further loci with few mismatches to the primers are very likely to be amplified as well. PCR-products were subsequently cloned, and individual cDNA clones were sequenced. HERV-W env cDNA sequences were assigned to specific HERV-W env loci in the human genome, based on characteristic nucleotide differences between HERV-W env loci (see also Figure 2).
###end p 17
###begin p 18
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 0 38 0 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of HERV-W <italic>env </italic>in human PBMC</bold>
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env</italic>
###xml 238 242 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 284 285 284 285 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 14 18 <span type="species:ncbi:11827">HERV</span>
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 53 57 <span type="species:ncbi:11827">HERV</span>
###xml 124 129 <span type="species:ncbi:9606">human</span>
###xml 231 235 <span type="species:ncbi:11827">HERV</span>
Expression of HERV-W env in human PBMC. RT-PCR using HERV-W env-specific primers was carried out on total RNA isolated from human PBMC which was subjected (+) or not (-) to reverse transcription. The expected size of the amplified HERV-W env fragment is ~640 bp. M, DNA size marker; H2O, PCR negative control.
###end p 18
###begin p 19
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Examples of recombined HERV-W <italic>env </italic>cDNA sequences</bold>
###xml 155 159 155 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 248 252 248 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 331 335 331 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 403 407 403 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 494 498 494 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 23 27 <span type="species:ncbi:11827">HERV</span>
###xml 112 117 <span type="species:ncbi:9606">human</span>
###xml 148 152 <span type="species:ncbi:11827">HERV</span>
###xml 206 211 <span type="species:ncbi:9606">human</span>
###xml 241 245 <span type="species:ncbi:11827">HERV</span>
###xml 324 328 <span type="species:ncbi:11827">HERV</span>
###xml 396 400 <span type="species:ncbi:11827">HERV</span>
###xml 487 491 <span type="species:ncbi:11827">HERV</span>
###xml 533 540 <span type="species:ncbi:9606">patient</span>
Examples of recombined HERV-W env cDNA sequences. A multiple alignment of the genomic DNA sequences (March 2006 human genome assembly) of the seven HERV-W env loci identified as transcriptionally active in human PBMC in this study is shown. HERV-W env loci are designated according to their chromosomal location. The 7q21.2 HERV-W env locus (ERVWE1) serves as reference sequence. Note that the 7 HERV-W env loci can be distiguished by unique nucleotides and/or indels. Two of the cloned HERV-W env cDNA sequences, MS-III-K11 (from a patient with MS) and KO-IV-K6 (from a healthy control) are shown as examples of recombined cDNAs. The proviral origin of cDNA sequence portions is indicated by a color code. Gray shaded areas represent regions in which recombination events have taken place. Sequences of the primers used in this study are underlined.
###end p 19
###begin p 20
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 184 185 184 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 201 205 201 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 251 255 251 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 412 416 412 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 459 463 459 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 521 522 521 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 584 588 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 874 878 874 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1315 1319 1315 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag </italic>
###xml 1358 1362 1358 1362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pol </italic>
###xml 1403 1407 1403 1407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1444 1445 1444 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1499 1503 1499 1503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1654 1656 1654 1656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1703 1705 1703 1705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1706 1708 1706 1708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 64 68 <span type="species:ncbi:11827">HERV</span>
###xml 194 198 <span type="species:ncbi:11827">HERV</span>
###xml 244 248 <span type="species:ncbi:11827">HERV</span>
###xml 299 304 <span type="species:ncbi:9606">human</span>
###xml 331 336 <span type="species:ncbi:9606">Human</span>
###xml 405 409 <span type="species:ncbi:11827">HERV</span>
###xml 424 429 <span type="species:ncbi:9606">human</span>
###xml 452 456 <span type="species:ncbi:11827">HERV</span>
###xml 577 581 <span type="species:ncbi:11827">HERV</span>
###xml 695 700 <span type="species:ncbi:9606">human</span>
###xml 747 751 <span type="species:ncbi:11827">HERV</span>
###xml 793 797 <span type="species:ncbi:11827">HERV</span>
###xml 867 871 <span type="species:ncbi:11827">HERV</span>
###xml 1396 1400 <span type="species:ncbi:11827">HERV</span>
###xml 1492 1496 <span type="species:ncbi:11827">HERV</span>
###xml 1548 1553 <span type="species:ncbi:9606">human</span>
###xml 1591 1595 <span type="species:ncbi:11827">HERV</span>
###xml 1798 1802 <span type="species:ncbi:11827">HERV</span>
###xml 1911 1915 <span type="species:ncbi:11827">HERV</span>
From each individual, we generated a median of 42 (range 40-44) HERV-W env cDNA clones, resulting in a total of 332 cDNA clones, the sequences of which are provided in additional file 1. To map HERV-W env cDNA sequences onto individual genomic HERV-W env loci, all 332 sequences were analyzed using human BLAT searches at the UCSC Human Genome Browser [36]. We thereby identified, in total, 7 transcribed HERV-W env loci in human PBMC. A list of those HERV-W env loci and their main characteristics are provided in Table 1[37]. In particular, the previously well characterized HERV-W env locus on chromosome 7q21.2 (ERVWE1), that is, the gene encoding Syncytin-1, was found to be transcribed in human PBMC. The 7q21.2 locus contains a full-length HERV-W proviral copy, flanked by two complete HERV-W LTRs. As for the structure of the other 6 transcriptionally active HERV-W env loci, all of them display incomplete 3'LTRs ending just downstream from the poly-A signal, the expected 3' end of the LTR R-region. In addition, two of those 6 elements (located on chromosome 6q21, and 15q21.3) show a deletion of the 5' LTR's first 255 nucleotides, corresponding to the expected LTR U3 region. The four remaining elements (5q11.2, 14q21.3, 17q12, and Xq22.3) are severely truncated at the 5' end, lacking the 5'LTR, the gag region, and varying portions of the 5' pol region. Structures of transcribed HERV-W env loci are provided in additional file 2. In summary, except for the 7q21.2 locus, all HERV-W env loci found to be transcriptionally active in human PBMC show characteristic features of HERV-W pseudogenes that have been generated by LINE machinery [11]. In keeping with results obtained by others [38,39], our data therefore indicate that despite having truncated or completely missing 5'LTRs HERV-W pseudogenes can be transcribed. This implies that as yet unidentified promotors located upstream of those HERV-W pseudogenes drive their transcription.
###end p 20
###begin p 21
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 19 23 <span type="species:ncbi:11827">HERV</span>
###xml 78 83 <span type="species:ncbi:9606">human</span>
Characteristics of HERV-W env loci identified in this study as transcribed in human PBMC
###end p 21
###begin p 22
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 281 285 281 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 53 57 <span type="species:ncbi:11827">HERV</span>
###xml 168 173 <span type="species:ncbi:9606">human</span>
###xml 274 278 <span type="species:ncbi:11827">HERV</span>
###xml 327 331 <span type="species:ncbi:11827">HERV</span>
###xml 574 578 <span type="species:ncbi:11827">HERV</span>
The chromosomal location of transcriptionally active HERV-W env loci is indicated in the first column. Nucleotide positions of amplicons on the respective chromosomes (human genome sequence March 2006 assembly) are indicated. Structures of the 5' and 3' LTRs of transcribed HERV-W env loci are given with respect to the 780-bp HERV-W LTR consensus sequence (LTR17) obtained from Repbase [37]. Missing nucleotides (Delta) in the LTRs as compared to the consensus LTR sequence are indicated. All but one locus represent processed pseudogenes. Presence of full length ORFs for HERV-W Env proteins is given in the final column.
###end p 22
###begin p 23
###xml 92 96 <span type="species:ncbi:11827">HERV</span>
* The Xq22.3 locus contains an ORF for a hypothetical N-terminally truncated 475 amino acid HERV-W Env protein.
###end p 23
###begin p 24
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 318 322 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 464 468 464 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 576 580 576 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 67 71 <span type="species:ncbi:11827">HERV</span>
###xml 115 119 <span type="species:ncbi:11827">HERV</span>
###xml 157 161 <span type="species:ncbi:11827">HERV</span>
###xml 252 256 <span type="species:ncbi:11827">HERV</span>
###xml 569 573 <span type="species:ncbi:11827">HERV</span>
###xml 646 650 <span type="species:ncbi:11827">HERV</span>
In accordance with previous analyses of the coding capacity of the HERV-W family [14,15,40], except for the 7q21.2 HERV-W env locus, none of the transcribed HERV-W env loci disclosed ORFs for full-length Env proteins. Still, a transcriptionally active HERV-W env locus on chromosome Xq22.3 contains an almost complete env ORF, only interrupted by a single premature stop codon in its 5' region (codon 39) followed by several in-frame ATGs. If the longest possible env ORF from this transcribed locus were translated, starting at an in-frame ATG at codon 68, the Xq22.3 HERV-W env locus could give rise to an N-terminally truncated 475 amino acid HERV-W Env protein.
###end p 24
###begin title 25
###xml 22 26 <span type="species:ncbi:11827">HERV</span>
A close inspection of HERV-W env cDNAs reveals a high number of recombined sequences
###end title 25
###begin p 26
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 296 300 296 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 401 405 401 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 576 580 576 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 894 903 894 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1030 1032 1030 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1187 1191 1187 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1215 1219 1215 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1333 1337 1333 1337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1445 1449 1445 1449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1610 1611 1610 1611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 11 15 <span type="species:ncbi:11827">HERV</span>
###xml 99 103 <span type="species:ncbi:11827">HERV</span>
###xml 160 164 <span type="species:ncbi:11827">HERV</span>
###xml 289 293 <span type="species:ncbi:11827">HERV</span>
###xml 394 398 <span type="species:ncbi:11827">HERV</span>
###xml 569 573 <span type="species:ncbi:11827">HERV</span>
###xml 784 788 <span type="species:ncbi:11827">HERV</span>
###xml 852 856 <span type="species:ncbi:11827">HERV</span>
###xml 1180 1184 <span type="species:ncbi:11827">HERV</span>
###xml 1208 1212 <span type="species:ncbi:11827">HERV</span>
###xml 1326 1330 <span type="species:ncbi:11827">HERV</span>
###xml 1438 1442 <span type="species:ncbi:11827">HERV</span>
Ideally, a HERV-W env cDNA sequence is expected to display no nucleotide mismatches to the genomic HERV-W env locus that it originated from. About one third of HERV-W env cDNAs analyzed in this work indeed perfectly matched with genomic DNA sequences. However, the remaining two thirds of HERV-W env cDNAs contained between 1 and 24 nucleotide differences compared to the best matching genomic HERV-W env locus. Although minor nucleotide differences may well be explained by the inaccuracy of Taq polymerase, sequencing errors, or sequence variations (SNPs) in genomic HERV-W env loci, those possibilities seem unlikely to account for the relatively high numbers of nucleotide mismatches observed in some of the cDNA sequences. It has recently been shown that analyses of transcribed HERV sequences are complicated by recombinations between individual HERV transcripts, which most likely arise in vitro during reverse transcription because of template switches of reverse transcriptase and/or through PCR-mediated recombinations [41]. To investigate whether similar recombinations also occurred in the present study, we generated multiple sequence alignments of the 7 transcribed HERV-W env loci and the 332 HERV-W env cDNA sequences. A close inspection of multiple alignments unambiguously demonstrated that a high number of HERV-W env cDNAs, that is, 99 out of 332 (29.8%), represented recombinations between transcripts from different HERV-W env loci. Notably, the alleged breakpoints of recombined sequences appeared to be randomly distributed. Typical examples of recombined sequences are shown in Figure 2.
###end p 26
###begin p 27
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 129 133 129 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 353 357 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 400 404 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 680 684 680 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 808 812 808 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 824 825 824 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 75 79 <span type="species:ncbi:11827">HERV</span>
###xml 122 126 <span type="species:ncbi:11827">HERV</span>
###xml 346 350 <span type="species:ncbi:11827">HERV</span>
###xml 393 397 <span type="species:ncbi:11827">HERV</span>
###xml 673 677 <span type="species:ncbi:11827">HERV</span>
###xml 801 805 <span type="species:ncbi:11827">HERV</span>
When assuming recombinations, the number of nucleotide differences between HERV-W env cDNAs and the best matching genomic HERV-W env loci was strongly reduced compared to the number of nucleotide mismatches when recombinations were not assumed (Figure 3). Within the ~640 bp sequence analyzed, the average number of nucleotide mismatches between HERV-W env cDNAs and the best matching genomic HERV-W env loci was 3.69 per 640 bp (= 5.77/kb) when no recombinations were asssumed, as opposed to 0.98 per 640 bp (= 1.53/kb) when recombinations were assumed. The majority of recombined cDNAs (67%) resulted from one recombination event involving transcripts from two different HERV-W env loci. As for the other sequences, we were able to detect up to 4 recombination events involving up to five different HERV-W env loci (Table 2).
###end p 27
###begin p 28
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 11 15 <span type="species:ncbi:11827">HERV</span>
Recombined HERV-W env cDNA sequences generated in this study
###end p 28
###begin p 29
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 133 137 133 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 76 80 <span type="species:ncbi:11827">HERV</span>
###xml 126 130 <span type="species:ncbi:11827">HERV</span>
Recombinations were detected by inspection of multiple alignments of cloned HERV-W env cDNA sequences and transcribed genomic HERV-W env loci identified in this work (for details, see Methods). Altogether, 99 out of 332 (29.8%) cDNA sequences analyzed represented recombined sequences. The sum of RNA transcripts from which recombined cDNA orignated is given in the right column. In the case that multiply recombined sequences involved the same locus more than once, it was assumed that sequences from the same locus originated from different transcripts from that locus.
###end p 29
###begin p 30
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 0 88 0 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Nucleotide mismatches between HERV-W <italic>env </italic>cDNAs and best matching genomic HERV-W <italic>env </italic>loci</bold>
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 221 225 221 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 282 286 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 386 390 386 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 435 439 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 510 514 510 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 30 34 <span type="species:ncbi:11827">HERV</span>
###xml 73 77 <span type="species:ncbi:11827">HERV</span>
###xml 155 159 <span type="species:ncbi:11827">HERV</span>
###xml 214 218 <span type="species:ncbi:11827">HERV</span>
###xml 275 279 <span type="species:ncbi:11827">HERV</span>
###xml 379 383 <span type="species:ncbi:11827">HERV</span>
###xml 428 432 <span type="species:ncbi:11827">HERV</span>
###xml 503 507 <span type="species:ncbi:11827">HERV</span>
Nucleotide mismatches between HERV-W env cDNAs and best matching genomic HERV-W env loci. White bars represent the number of nucleotide mismatches between HERV-W env cDNAs (n = 332) and their best matching genomic HERV-W env locus without assuming the presence of recombined HERV-W env sequences among those cDNAs. Black bars indicate the number of nucleotide mismatches between HERV-W env cDNAs and their best matching genomic HERV-W env loci when the presence of recombination events in 99 out of 332 HERV-W env cDNAs (see Table 2) was taken into account.
###end p 30
###begin title 31
###xml 41 45 <span type="species:ncbi:11827">HERV</span>
###xml 60 65 <span type="species:ncbi:9606">human</span>
Differential transcriptional activity of HERV-W env loci in human PBMC
###end title 31
###begin p 32
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 377 381 377 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 578 579 578 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 659 663 659 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 714 718 714 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 856 860 856 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 99 103 <span type="species:ncbi:11827">HERV</span>
###xml 228 232 <span type="species:ncbi:11827">HERV</span>
###xml 265 269 <span type="species:ncbi:11827">HERV</span>
###xml 370 374 <span type="species:ncbi:11827">HERV</span>
###xml 652 656 <span type="species:ncbi:11827">HERV</span>
###xml 671 676 <span type="species:ncbi:9606">human</span>
###xml 707 711 <span type="species:ncbi:11827">HERV</span>
###xml 849 853 <span type="species:ncbi:11827">HERV</span>
Supposing that the relative cloning frequencies (the number of cDNA clones from a given individual HERV-W env locus relative to all cDNA clones analyzed) roughly reflect the relative abundance of RNA transcripts from individual HERV-W env loci in the total pool of HERV-W env RNAs in PBMCs, it is possible to estimate the relative transcriptional activity of individual HERV-W env loci in PBMC [34,35]. In a first analysis of pooled data from all 8 individuals studied, we used the 233 non-recombined cDNA sequences to calculate relative cloning frequencies. As shown in Figure 4, this demonstrated a differential transcriptional activity of expressed HERV-W env loci in human PBMC, with transcripts from a HERV-W env locus on chromosome 15q21.3 being most abundant (111 out of 233 sequences [47.6%]). In contrast, cDNAs from the 14q21.3 and 5q11.2 HERV-W env loci were only very rarely cloned (1 sequence from each locus out of 233 sequences [0.4%]).
###end p 32
###begin p 33
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Relative cloning frequencies of transcriptionally active HERV-W <italic>env </italic>loci in human PBMC</bold>
###xml 185 189 185 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 57 61 <span type="species:ncbi:11827">HERV</span>
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 178 182 <span type="species:ncbi:11827">HERV</span>
Relative cloning frequencies of transcriptionally active HERV-W env loci in human PBMC. The relative cloning frequencies are given as the number of cDNA clones from a particular HERV-W env locus relative to the number of all cDNA clones analyzed. Frequencies were calculated separately for all non-recombined clones (n = 233 sequences; white bars), all recombined clones (n = 99 sequences, originating from 238 transcripts [see text and Table 2]; black bars), and for non-recombined and recombined clones together (n = 332; originating from 471 transcripts [see text and Table 2]; gray bars).
###end p 33
###begin p 34
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 53 57 <span type="species:ncbi:11827">HERV</span>
To compare the transcriptional activity of different HERV-W env loci the PCR efficiencies with which these loci are amplified should be similar. PCR-efficiency mostly relies on the binding of primers to their target sequences. As can be seen in Figure 2, three of the seven amplified loci (7q21.2, 17q12, Xq22.3) perfectly matched to the primers and are thus expected to be amplified with similar efficiencies. The binding regions of three further loci (5q11.2, 6q21, 15q21.3) contained a single nucleotide mismatch in the 5' end of either the forward or the reverse primer. Because the 15q21.3 and the 6q21 loci were the most frequently cloned loci in our study, the single nucleotide mismatches in these two loci appear unlikely to have had a significant negative impact on amplification. In the case of the 5q11.2 locus this possibility cannot be excluded, but seems unlikely given the results for the 15q21.3 and 6q21 loci. One locus (14q21.3) displayed one additional nucleotide and one nucleotide mismatch in the binding region of the forward primer, and it seems possible that those mismatches may have negatively affected its amplification.
###end p 34
###begin p 35
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 501 502 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 32 36 <span type="species:ncbi:11827">HERV</span>
###xml 85 89 <span type="species:ncbi:11827">HERV</span>
###xml 285 289 <span type="species:ncbi:11827">HERV</span>
Since the finding of recombined HERV-W env cDNA sequences implies that the different HERV-W env loci that contributed to the recombined sequences must have been transcribed, we also estimated relative cloning frequencies based on the 99 recombined sequences, counting individually all HERV-W env loci that were present in the recombined sequences (see also Table 2). The relative cloning frequencies obtained in this evaluation were overall comparable to those of the non-recombined sequences (Figure 4), suggesting that the likelihood of taking part in recombinations correlates with transcript abundance.
###end p 35
###begin p 36
###xml 347 351 347 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 340 344 <span type="species:ncbi:11827">HERV</span>
Finally, not all transcriptionally active loci were detected as cDNA in every individual. Regarding non-recombined and recombined sequences together, transcripts from the 5q11.2 locus were detected in one, transcripts from the 14q21.3 in three, and transcripts from the 7q21.2 locus in seven of the eight individuals studied. The remaining HERV-W env loci (6q21, 15q21.3, 17q12, Xq22.3) were found to be transcriptionally active in the PBMC of every individual studied.
###end p 36
###begin title 37
###xml 47 51 <span type="species:ncbi:11827">HERV</span>
###xml 76 84 <span type="species:ncbi:9606">patients</span>
Similar transcriptional activity of individual HERV-W env loci in PBMC from patients with MS and healthy controls
###end title 37
###begin p 38
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 378 379 378 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 477 478 477 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 562 566 562 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 717 721 717 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 834 838 834 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 109 113 <span type="species:ncbi:11827">HERV</span>
###xml 140 148 <span type="species:ncbi:9606">patients</span>
###xml 247 251 <span type="species:ncbi:11827">HERV</span>
###xml 555 559 <span type="species:ncbi:11827">HERV</span>
###xml 710 714 <span type="species:ncbi:11827">HERV</span>
###xml 827 831 <span type="species:ncbi:11827">HERV</span>
###xml 861 869 <span type="species:ncbi:9606">patients</span>
We next evaluated whether the relative cloning frequencies and thus transcriptional activities of individual HERV-W env loci differ between patients with MS and healthy controls. Since the general pattern of transcriptional activity of individual HERV-W env loci was essentially the same regardless of whether recombined sequences were included in the evaluation or not (Figure 4), we analyzed data from all (non-recombined and recombined) sequences (see also Table 2). Figure 5 shows that the variability of the transcriptional activity of the different HERV-W env loci among the different individuals studied was overall quite high, suggesting inter-individual differences in the transcriptional activity of HERV-W env loci. However, there were no significant differences in the relative cloning frequencies of the different HERV-W env loci when the group of patients with MS was compared with the group of healthy controls (p > 0.05; two-tailed Fisher's exact test).
###end p 38
###begin p 39
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 0 129 0 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Relative cloning frequencies of transcriptionally active HERV-W <italic>env </italic>loci in human PBMC from patients with MS and healthy controls</bold>
###xml 452 456 452 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 57 61 <span type="species:ncbi:11827">HERV</span>
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 92 100 <span type="species:ncbi:9606">patients</span>
###xml 445 449 <span type="species:ncbi:11827">HERV</span>
###xml 483 491 <span type="species:ncbi:9606">patients</span>
###xml 598 606 <span type="species:ncbi:9606">patients</span>
Relative cloning frequencies of transcriptionally active HERV-W env loci in human PBMC from patients with MS and healthy controls. Relative cloning frequencies were calculated for recombined and non-recombined clones together (n = 332 sequences, originating from 471 transcripts [see text and Table 2]). The box represents the mean, and the whiskers represent the minimum and maximum of the relative cloning frequencies of cDNAs from individual HERV-W env elements for the groups of patients with MS (n = 4) and healthy controls (n = 4). There were no statistically significant differences between patients and controls (p > 0.05; two-tailed Fisher's exact test).
###end p 39
###begin title 40
###xml 61 65 <span type="species:ncbi:11827">HERV</span>
MSRV sequences can be explained as originating from distinct HERV-W loci and recombinations among them
###end title 40
###begin p 41
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 185 189 185 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 223 232 223 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 262 266 262 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 345 349 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 445 449 445 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 465 466 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 581 585 581 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 620 629 620 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a priori </italic>
###xml 43 47 <span type="species:ncbi:11827">HERV</span>
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 178 182 <span type="species:ncbi:11827">HERV</span>
###xml 255 259 <span type="species:ncbi:11827">HERV</span>
Having identified transcriptionally active HERV-W env loci in human PBMC, we were interested to know how previously published MSRV env sequences are related to those transcribed HERV-W env loci. Given the high frequency of in vitro recombinations between HERV-W env transcripts, we also wondered whether recombinations may be detectable in MSRV env sequences. To this end, we retrieved published MSRV sequences comprising parts of or the entire env region (n = 5) [7,23] from the NCBI database and analyzed them by BLAT searches (see Methods for details). Since all published MSRV env sequences are heterogeneous, it is a priori unlikely that all those sequences are derived from a single proviral insertion.
###end p 41
###begin p 42
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 249 253 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 587 588 587 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 758 759 758 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 869 870 869 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 938 942 938 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1109 1113 1109 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1301 1305 1301 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 137 141 <span type="species:ncbi:11827">HERV</span>
###xml 163 167 <span type="species:ncbi:11827">HERV</span>
###xml 342 346 <span type="species:ncbi:11827">HERV</span>
###xml 403 407 <span type="species:ncbi:11827">HERV</span>
###xml 515 519 <span type="species:ncbi:11827">HERV</span>
###xml 685 689 <span type="species:ncbi:11827">HERV</span>
###xml 825 829 <span type="species:ncbi:11827">HERV</span>
###xml 885 889 <span type="species:ncbi:11827">HERV</span>
###xml 995 1000 <span type="species:ncbi:9606">human</span>
###xml 1042 1046 <span type="species:ncbi:11827">HERV</span>
###xml 1186 1191 <span type="species:ncbi:9606">human</span>
###xml 1294 1298 <span type="species:ncbi:11827">HERV</span>
###xml 1360 1364 <span type="species:ncbi:11827">HERV</span>
###xml 1497 1501 <span type="species:ncbi:11827">HERV</span>
Quite strikingly, three of the MSRV env containing sequences (AF127227, AF127228, AF123882) could each be assigned to a distinct genomic HERV-W locus, namely, the HERV-W elements on chromosome 3q23, Xq22.3, and 15q21.3 (Table 3). The other two MSRV env sequences (AF127229 and AF331500) could be explained as recombinations between different HERV-W loci. AF127229 represents a recombination between two HERV-W loci located on chromsome 3p12.3 and 18q21.32. Likewise, AF331500 represents a recombination between two HERV-W elements on Xq22.3 and 5p12. Similar to the data shown in Figure 3, the number of nucleotide mismatches between AF127229 or AF331500 and the best matching genomic HERV-W loci was strongly reduced when recombinations were assumed (Table 3). Alignments of MSRV sequences with the respective best matching HERV-W loci are provided in additional file 3. Notably, two HERV-W elements (15q21.3 and Xq22.3) from which MSRV env sequences originated were found to be transcribed in human PBMC in the present work. The four other HERV-W elements (3q23, 3p12.3, 18q21.32, and 5p12) from which MSRV env sequences are derived were not identified as transcriptionally active in human PBMC in our investigation. However, due to various deletions the binding sites for one or both of the HERV-W env primers employed in our work are missing in those four HERV-W loci, indicating that corresponding cDNAs could not be amplified (data not shown). Therefore, it remains possible that those four HERV-W loci are transcriptionally active, too.
###end p 42
###begin p 43
Origin of previously described MSRV sequences
###end p 43
###begin p 44
###xml 84 88 <span type="species:ncbi:11827">HERV</span>
###xml 107 112 <span type="species:ncbi:9606">human</span>
###xml 246 250 <span type="species:ncbi:11827">HERV</span>
###xml 421 425 <span type="species:ncbi:11827">HERV</span>
###xml 686 690 <span type="species:ncbi:11827">HERV</span>
Previously published MSRV sequences were assigned by BLAT searches to corresponding HERV-W elements in the human genome. The accession number and length (base pairs, bp) of published MSRV clones are provided in the left column. The best matching HERV-W locus or loci (in case of recombined sequences) are indicated in column 2, and the number of nucleotide mismatches between MSRV sequences and the best matching genomic HERV-W elements in column 3. Note that for the recombined sequences, the number of nucleotide mismatches after assuming recombinations is markedly reduced. The average number of nucleotide differences of the 6 analyzed MSRV sequences to their best matching genomic HERV-W locus/loci was 1.97/kb. n.a., not applicable
###end p 44
###begin p 45
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag </italic>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 248 252 248 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag </italic>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 362 366 362 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag </italic>
###xml 417 421 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag </italic>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 87 91 <span type="species:ncbi:11827">HERV</span>
###xml 130 134 <span type="species:ncbi:11827">HERV</span>
###xml 203 208 <span type="species:ncbi:9606">human</span>
###xml 241 245 <span type="species:ncbi:11827">HERV</span>
###xml 355 359 <span type="species:ncbi:11827">HERV</span>
###xml 410 414 <span type="species:ncbi:11827">HERV</span>
###xml 432 437 <span type="species:ncbi:9606">human</span>
###xml 491 495 <span type="species:ncbi:11827">HERV</span>
We could also assign the formerly published MSRV gag sequence (AF123881) to a distinct HERV-W element on chromosome 3q26.32. This HERV-W locus has formerly been identified as transcriptionally active in human PBMC [39] and is identical to a HERV-W gag gene on chromosome 3 (AF156961), previously characterized by Voisset et al. [14]. Although the 3q26.32 HERV-W gag gene is incomplete, it contains the largest HERV-W gag ORF in the human genome, with a putative coding capacity for a 45 kDa HERV-W Gag protein, consisting of a complete matrix domain and a C-terminally truncated capsid, but lacking nucleocapsid [14].
###end p 45
###begin p 46
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 74 78 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag </italic>
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 129 133 <span type="species:ncbi:11827">HERV</span>
###xml 232 236 <span type="species:ncbi:11827">HERV</span>
###xml 251 256 <span type="species:ncbi:9606">human</span>
###xml 371 375 <span type="species:ncbi:11827">HERV</span>
Notably, the average number of nucleotide mismatches between MSRV env and gag sequences and the respective best matching genomic HERV-W loci (1.97/kb; see Table 3) were in the same range as that observed in our study of transcribed HERV-W env loci in human PBMC (1.53/kb). In summary, our analyses suggest that previously published MSRV sequences originated from genomic HERV-W loci, or recombinations among them.
###end p 46
###begin title 47
###xml 28 32 <span type="species:ncbi:11827">HERV</span>
Relationship between Xq22.3 HERV-W env and MSRV env
###end title 47
###begin p 48
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 121 125 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 439 443 439 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 552 556 552 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 564 565 564 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 756 760 756 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 838 842 838 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 896 900 896 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 993 994 993 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 1047 1051 1047 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1107 1111 1107 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1318 1322 1318 1322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 114 118 <span type="species:ncbi:11827">HERV</span>
###xml 209 213 <span type="species:ncbi:11827">HERV</span>
###xml 497 501 <span type="species:ncbi:11827">HERV</span>
###xml 545 549 <span type="species:ncbi:11827">HERV</span>
###xml 604 608 <span type="species:ncbi:11827">HERV</span>
###xml 831 835 <span type="species:ncbi:11827">HERV</span>
###xml 889 893 <span type="species:ncbi:11827">HERV</span>
###xml 935 939 <span type="species:ncbi:11827">HERV</span>
###xml 1100 1104 <span type="species:ncbi:11827">HERV</span>
###xml 1311 1315 <span type="species:ncbi:11827">HERV</span>
The MSRV env clone AF127228 and the SU and N-terminal TM regions of the MSRV env clone AF331500 correspond to the HERV-W env element on chromosome Xq22.3 which harbors a long ORF for a putative 475 amino acid HERV-W Env protein (Table 3). Accordingly, the amino acid sequence of a recombinant MSRV Env SU protein, which has been shown to have proinflammatory effects in various assays [24], and which was generated using the AF331500 MSRV env clone, is identical to the amino acid sequence of the HERV-W Env protein putatively encoded by Xq22.3 HERV-W env (Figure 6) [42]. However, in contrast to Xq22.3 HERV-W Env which is N-terminally truncated due to a stop codon (TGA) at position 39, this stop codon is a tryptophan residue (TGG) in the AF331500 MSRV env clone. Remarkably, the elimination of the stop codon at position 39 of HERV-W env Xq22.3 results in an uninterrupted full-length HERV-W env ORF, which could encode a complete HERV-W Env protein that contains a signal peptide (Figure 6). The origin of the stop codon mutation in the MSRV env AF331500 clone is unknown. Since several genomic HERV-W env elements display a TGG at the particular position, it is conceivable that a recombination event involving transcripts from the Xq22.3 locus and a short sequence stretch from one of the TGG containing HERV-W env loci might account for the reversal of the stop codon (data not shown).
###end p 48
###begin p 49
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Relationship between Xq22.3 HERV-W Env, MSRV Env, and Syncytin-1</bold>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 352 353 352 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1061 1065 1061 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1108 1110 1108 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1155 1159 1155 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1244 1246 1244 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 28 32 <span type="species:ncbi:11827">HERV</span>
###xml 109 113 <span type="species:ncbi:11827">HERV</span>
###xml 205 209 <span type="species:ncbi:11827">HERV</span>
###xml 509 513 <span type="species:ncbi:11827">HERV</span>
###xml 662 666 <span type="species:ncbi:11827">HERV</span>
###xml 1206 1210 <span type="species:ncbi:11827">HERV</span>
Relationship between Xq22.3 HERV-W Env, MSRV Env, and Syncytin-1. An amino acid sequence alignment of Xq22.3 HERV-W Env, MSRV Env (clones AF127228 and AF331500), and Syncytin-1 is shown. The sequence of a HERV-W element on chromosome 5p12 from which the C-terminal region of the MSRV env clone AF331500 is derived (see also Table 3 and Additional file 2) is also shown. For the sake of simplicity, only the C-terminal region of the 5p12 element is included. The region of MSRV Env (AF331500) originating from HERV-W 5p12 is highlighted in yellow. Predicted signal peptides (according to SignalP 3.0, ) are shaded in gray. The stop codon at position 39 of Xq22.3 HERV-W Env and AF127228 is indicated by a dot (.). The consensus C-X-X-C motif conserved among C-type and D-type retroviral Env proteins [42] is shown in boldface. The border between the SU and TM regions is indicated by arrows. The proteolytic cleavage site (consensus R/K-X-R/K-R) between SU and TM is highlighted in red letters. The sequences of the MSRV Env SU protein (generated using the MSRV env clone AF331500) studied by Rolland et al. [24] is marked in red. The fragment of the MSRV env clone AF127228 used for generation of the anti HERV-W Env monoclonal antibody 6A2B2 [16] is shown in green.
###end p 49
###begin p 50
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 216 220 216 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 352 353 352 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 651 653 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 796 798 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 799 801 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 842 846 842 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1043 1047 1043 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 96 100 <span type="species:ncbi:11827">HERV</span>
###xml 209 213 <span type="species:ncbi:11827">HERV</span>
###xml 301 305 <span type="species:ncbi:11827">HERV</span>
###xml 504 508 <span type="species:ncbi:11827">HERV</span>
###xml 828 832 <span type="species:ncbi:11827">HERV</span>
###xml 883 887 <span type="species:ncbi:11827">HERV</span>
###xml 1036 1040 <span type="species:ncbi:11827">HERV</span>
In contrast to AF331500, the MSRV env clone AF127228, which likewise originates from the Xq22.3 HERV-W env locus, displays the stop codon at position 39. A DNA fragment comprising amino acids 68 to 446 of the HERV-W env ORF encoded by AF127228 has previously been used to generate the monoclonal anti HERV-W Env antibody 6A2B2 [16]. As shown in Figure 6, except for two amino acid exchanges in its C-terminus, the AF127228 amino acids 68 to 446 sequence is identical to the amino acid sequence of Xq22.3 HERV-W Env, but displays 38 mismatches to the Syncytin-1 amino acid sequence. Nevertheless, the 6A2B2 antibody may cross react with Syncytin-1 [16,43] and all previous neuropathological studies that reported a dysregulated expression of Syncytin-1 in MS lesions relied on the 6A2B2 antibody [18,21,22]. Still, assuming that HERV-W Xq22.3 env may have the potential to code for a HERV-W Env protein, our findings open the intriguing possibility that the protein detected by 6A2B2 in MS lesions could instead have originated from the HERV-W env locus on chromosome Xq22.3.
###end p 50
###begin title 51
Discussion
###end title 51
###begin p 52
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 365 369 365 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 535 539 535 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 632 636 632 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 710 714 710 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 883 887 883 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1036 1038 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1039 1041 1039 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1082 1086 1082 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1306 1310 1306 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1634 1636 1634 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1637 1639 1637 1639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1779 1781 1779 1781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 14 18 <span type="species:ncbi:11827">HERV</span>
###xml 37 42 <span type="species:ncbi:9606">human</span>
###xml 110 114 <span type="species:ncbi:11827">HERV</span>
###xml 133 137 <span type="species:ncbi:11827">HERV</span>
###xml 234 238 <span type="species:ncbi:11827">HERV</span>
###xml 298 303 <span type="species:ncbi:9606">human</span>
###xml 358 362 <span type="species:ncbi:11827">HERV</span>
###xml 403 411 <span type="species:ncbi:9606">patients</span>
###xml 528 532 <span type="species:ncbi:11827">HERV</span>
###xml 625 629 <span type="species:ncbi:11827">HERV</span>
###xml 677 682 <span type="species:ncbi:9606">human</span>
###xml 703 707 <span type="species:ncbi:11827">HERV</span>
###xml 876 880 <span type="species:ncbi:11827">HERV</span>
###xml 987 992 <span type="species:ncbi:9606">human</span>
###xml 1075 1079 <span type="species:ncbi:11827">HERV</span>
###xml 1299 1303 <span type="species:ncbi:11827">HERV</span>
###xml 1581 1586 <span type="species:ncbi:9606">human</span>
When studying HERV RNA expression in human diseases, it seems important to clearly dissect from which genomic HERV loci the detected HERV RNA transcripts originate [44]. Consistent with previous findings suggesting that expression of HERV transcripts is a ubiquitious phenomenon occurring in every human tissue [34,45,46], we herein show that at least seven HERV-W env loci are transcribed in PBMC from patients with MS and healthy controls. Since the primers used in this investigation only amplify a limited number of genomic HERV-W env elements our study is not exhaustive, and it seems rather likely that more than seven HERV-W env elements are transcriptionally active in human PBMC. Additionally, HERV-W env loci that are transcribed at very low rates could be missed in the cloning procedure unless much higher numbers of clones are generated. Three of the transcribed HERV-W env elements (15q21.3, Xq22.3, 17q12) identified in this study were previously found to be expressed in human PBMC by a cloning and sequencing approach [38,39]. Assignment of cDNAs to genomic HERV-W env loci in the former investigations was based on rather short sequences (30 bp, excluding primers), containing only few informative nucleotides, that is, nucleotides that are exclusively present in a single genomic HERV-W env locus and thereby allow unambiguous assignment of cDNAs. Usage of a ~600 bp sequence (excluding primers) in the present work resulted in a higher number of informative nucleotides and thus strengthened the accuracy of the assignment. Our finding of ERVWE1 transcripts in human PBMC is consistent with previous observations [19,20] and corroborates that although ERVWE1 expression is most abundant in placenta this locus is transcribed in non-placental tissues as well [15].
###end p 52
###begin p 53
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 205 209 205 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 296 300 296 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 341 345 341 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 485 489 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 772 776 772 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 907 911 907 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1063 1065 1063 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1066 1068 1066 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1182 1186 1182 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1225 1229 1225 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 44 48 <span type="species:ncbi:11827">HERV</span>
###xml 88 96 <span type="species:ncbi:9606">patients</span>
###xml 198 202 <span type="species:ncbi:11827">HERV</span>
###xml 289 293 <span type="species:ncbi:11827">HERV</span>
###xml 334 338 <span type="species:ncbi:11827">HERV</span>
###xml 478 482 <span type="species:ncbi:11827">HERV</span>
###xml 597 605 <span type="species:ncbi:9606">patients</span>
###xml 765 769 <span type="species:ncbi:11827">HERV</span>
###xml 789 797 <span type="species:ncbi:9606">patients</span>
###xml 900 904 <span type="species:ncbi:11827">HERV</span>
###xml 947 955 <span type="species:ncbi:9606">patients</span>
###xml 997 1005 <span type="species:ncbi:9606">patients</span>
###xml 1175 1179 <span type="species:ncbi:11827">HERV</span>
###xml 1218 1222 <span type="species:ncbi:11827">HERV</span>
Several studies have analyzed expression of HERV-W env RNA in PBMC or brain tissue from patients with MS [18-21]. Lack of systematic cloning, sequencing, and assignment of cDNA sequences to genomic HERV-W env loci have impaired the exact identification of transcriptionally active genomic HERV-W env loci responsible for the observed HERV-W env RNA expression in these investigations. Whereas in the present detailed analysis we could identify distinct transcriptionally active HERV-W env loci, we did not observe significant differences in the transcriptional activity of those loci in PBMC from patients with MS versus healthy controls. Although the number of individuals studied was rather small, these data argue against a dysregulated transcription pattern of HERV-W env in PBMC from patients with MS. In contrast, a consistent finding of former investigations was a significantly higher global HERV-W env RNA expression in brain tissue from patients with MS as compared to brain tissue from patients with other neurological diseases or normal brain tissue [18-21]. Using the methodological approach of the present work, it will therefore be interesting to identify the HERV-W env elements underlying upregulated HERV-W env RNA expression in MS brain tissue.
###end p 53
###begin p 54
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 214 218 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 305 308 305 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink">deg</sub>
###xml 310 314 310 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 350 354 350 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 463 467 463 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 546 550 546 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 618 622 618 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 654 658 654 658 <sub xmlns:xlink="http://www.w3.org/1999/xlink">deg </sub>
###xml 658 662 658 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 702 706 702 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 727 731 727 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 833 837 833 837 <sub xmlns:xlink="http://www.w3.org/1999/xlink">deg </sub>
###xml 837 841 837 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 905 909 905 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 933 937 933 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 990 994 990 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1050 1054 1050 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 92 96 <span type="species:ncbi:11827">HERV</span>
###xml 207 211 <span type="species:ncbi:11827">HERV</span>
###xml 299 303 <span type="species:ncbi:11827">HERV</span>
###xml 456 460 <span type="species:ncbi:11827">HERV</span>
###xml 539 543 <span type="species:ncbi:11827">HERV</span>
###xml 611 615 <span type="species:ncbi:11827">HERV</span>
###xml 648 652 <span type="species:ncbi:11827">HERV</span>
###xml 695 699 <span type="species:ncbi:11827">HERV</span>
###xml 720 724 <span type="species:ncbi:11827">HERV</span>
###xml 765 773 <span type="species:ncbi:9606">patients</span>
###xml 827 831 <span type="species:ncbi:11827">HERV</span>
###xml 898 902 <span type="species:ncbi:11827">HERV</span>
###xml 926 930 <span type="species:ncbi:11827">HERV</span>
###xml 983 987 <span type="species:ncbi:11827">HERV</span>
###xml 1043 1047 <span type="species:ncbi:11827">HERV</span>
Antony and coworkers addressed this question by designing primers that specifically amplify HERV-W env 7q21.2 (ERVWE1) and the MSRV env clone AF123882 [20], which, as shown by our analyses, corresponds to a HERV-W env element on chromosome 15q21.3. These authors also employed a pair of degenerate (HERV-Wdeg) env primers that were based on the MSRV env clone AF331500, which, again as shown in this work, corresponds to a recombined cDNA originating from HERV-W env loci on Xq22.3 and 5p12. According to the Antony et al. study, elevated HERV-W env RNA expression in MS brain tissue originates mainly from the HERV-W env elements amplified by the HERV-Wdeg env primers and (somewhat less) from HERV-W env 7q21.2, while HERV-W env 15q21.3 expression was similar in patients and controls [20]. A BLAT-PCR search showed that the HERV-Wdeg env primer pair potentially amplifies at least three genomic HERV-W env loci, among them HERV-W env Xq22.3. It is thus tempting to speculate that HERV-W env Xq22.3 may significantly contribute to increased HERV-W env RNA expression in MS brain tissue. Again, using the methods described herein, this issue could be resolved in a straightforward manner.
###end p 54
###begin p 55
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 243 252 243 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 677 679 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1058 1067 1058 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 89 93 <span type="species:ncbi:11827">HERV</span>
###xml 154 160 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 614 620 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 736 742 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
Remarkably, we observed a high number (29.8%) of recombined sequences among the analyzed HERV-W env cDNAs. As detailed in a previous study on transcribed HERV-K(HML-2) sequences [41], those recombinant cDNA sequences very likely resulted from in vitro recombinations that were due to template switches of reverse transcriptase during cDNA synthesis and/or PCR-mediated recombinations. Both of these mechanisms are well-recognized and have been proven experimentally to produce chimeric sequences [41,47-53]. The percentage of recombined sequences detected in the present study was higher than that in the study on HERV-K(HML-2) in which ~5% of recombined clones were observed [41]. This is most likely explained by the fact that in the HERV-K(HML-2) study only cDNA sequences with more than 17 nucleotide mismatches to the best matching locus were analyzed for recombinations, whereas in the present work all cDNA sequences were scrutinized for recombinations. Altogether, our data indicate that during experimental studies of repetitive elements by RT-PCR, in vitro recombinations are relatively common and almost inevitable complications.
###end p 55
###begin p 56
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag </italic>
###xml 242 243 242 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 274 283 274 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 525 529 525 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 579 588 579 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 163 167 <span type="species:ncbi:11827">HERV</span>
###xml 333 337 <span type="species:ncbi:11827">HERV</span>
An important result of this investigation is that previously published MSRV env and gag sequences appear to either be derived from transcripts of specific genomic HERV-W elements or to result from recombinations among such transcripts (Table 3). Given the high frequency of in vitro recombinations between transcripts from different HERV loci observed in this and the study by Flockerzi et al. [41], and given that MSRV clones were generated by methodologically similar approaches, it seems possible that the recombined MSRV env sequences (AF127229, AF331500) have resulted from in vitro recombinations as well.
###end p 56
###begin p 57
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 246 254 246 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 315 319 315 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 547 548 547 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 575 584 575 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a priori </italic>
###xml 889 893 889 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 959 963 959 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1009 1013 1009 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1126 1130 1126 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 89 93 <span type="species:ncbi:11827">HERV</span>
###xml 177 181 <span type="species:ncbi:11827">HERV</span>
###xml 308 312 <span type="species:ncbi:11827">HERV</span>
###xml 488 492 <span type="species:ncbi:11827">HERV</span>
###xml 565 569 <span type="species:ncbi:11827">HERV</span>
###xml 647 652 <span type="species:ncbi:9606">human</span>
###xml 697 701 <span type="species:ncbi:11827">HERV</span>
###xml 712 717 <span type="species:ncbi:9606">human</span>
###xml 882 886 <span type="species:ncbi:11827">HERV</span>
###xml 1002 1006 <span type="species:ncbi:11827">HERV</span>
###xml 1119 1123 <span type="species:ncbi:11827">HERV</span>
###xml 1309 1313 <span type="species:ncbi:11827">HERV</span>
An alternative explanation is that the recombined MSRV env sequences, and the recombined HERV-W env sequences isolated in this study, originated from novel, recombined, genomic HERV-W insertions. Hypothetically, such insertions could have formed in vivo after recombination of RNA transcripts from different HERV-W env loci through template switches during reverse transcription. Although we cannot formally exclude this possibility, a number of points argue against it. First, all known HERV-W elements are defective and replication-incompetent [8,14]. Therefore, HERV-W is a priori rather unlikely to have the capacity to form new insertions in human DNA. Second, if there were novel recombined HERV-W loci in human DNA, one would expect to repeatedly observe defined recombined sequences originating from such insertions. However, this is neither the case with the 99 recombined HERV-W env cDNA sequences analyzed in this study nor with the published MSRV env clones. Third, given that about 30% of HERV-W env and 33% (2 of 6) of the investigated MSRV sequences represent recombinants, if all these recombinant MSRV/HERV-W env sequences were derived from novel proviral insertions, formation of such novel insertions would be an astonishingly frequent event. It seems very unlikely that as many recombined HERV-W loci should have been overlooked in previous genome sequencing projects.
###end p 57
###begin p 58
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag </italic>
###xml 212 221 212 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 354 358 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 692 693 692 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 855 856 855 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 857 859 857 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 860 862 860 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 935 939 935 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 943 947 943 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag </italic>
###xml 1143 1147 1143 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pol </italic>
###xml 1224 1226 1224 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1227 1229 1227 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 1288 1292 1288 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pol </italic>
###xml 1312 1316 1312 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pol </italic>
###xml 191 195 <span type="species:ncbi:11827">HERV</span>
###xml 259 263 <span type="species:ncbi:11827">HERV</span>
###xml 347 351 <span type="species:ncbi:11827">HERV</span>
###xml 404 408 <span type="species:ncbi:11827">HERV</span>
###xml 428 433 <span type="species:ncbi:9606">human</span>
###xml 1174 1182 <span type="species:ncbi:9606">patients</span>
###xml 1281 1285 <span type="species:ncbi:11827">HERV</span>
Collectively, the most plausible and simplest explanation for the origin of MSRV env and gag sequences seems to be that those sequences originate from RNA transcripts from various endogenous HERV-W loci, or from in vitro recombinations among them. All of the HERV-W loci from which MSRV sequences are derived are defective and except for the 5p12 HERV-W env element, all of those loci resemble processed HERV-W pseudogenes. The human genome sequence was not yet available when MSRV was described, which hampered the identification of the precise origin of MSRV sequences at that time. It was, however, noted that those sequences cannot be attributed to a single replication-competent genome [7]. Nevertheless, the nature of MSRV was subsequently controversial, and it has been speculated that MSRV could be an exogenous, replication-competent retrovirus [6,30-32]. In contrast, our present data clearly suggest that the published MSRV env and gag RNA sequences are not derived from the genome of a currently replication-competent exogenous retrovirus. In the light of these results and previous observations of an increased prevalence of MSRV pol transcripts in plasma from patients with MS as compared to healthy controls [54,55], it may similarly be interesting to analyze which HERV-W pol elements those MSRV pol transcripts could be derived from.
###end p 58
###begin p 59
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 268 272 268 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 504 508 504 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 746 747 746 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 922 926 922 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1037 1041 1037 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1050 1052 1050 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1109 1113 1109 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1279 1283 1279 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1333 1337 1333 1337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1407 1411 1407 1411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1557 1564 1557 1564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 125 129 <span type="species:ncbi:11827">HERV</span>
###xml 444 448 <span type="species:ncbi:11827">HERV</span>
###xml 497 501 <span type="species:ncbi:11827">HERV</span>
###xml 719 723 <span type="species:ncbi:11827">HERV</span>
###xml 915 919 <span type="species:ncbi:11827">HERV</span>
###xml 1030 1034 <span type="species:ncbi:11827">HERV</span>
###xml 1102 1106 <span type="species:ncbi:11827">HERV</span>
###xml 1161 1172 <span type="species:ncbi:9598">chimpanzees</span>
###xml 1272 1276 <span type="species:ncbi:11827">HERV</span>
###xml 1326 1330 <span type="species:ncbi:11827">HERV</span>
###xml 1400 1404 <span type="species:ncbi:11827">HERV</span>
###xml 1448 1453 <span type="species:ncbi:9606">human</span>
Although our findings argue against MSRV being an autonomous retroviral entity, they do by no means rule out that individual HERV-W env loci that correspond to MSRV sequences, or the Syncytin-1 (ERVWE1) gene, could be of relevance in MS. Indeed, we show that two MSRV env clones (AF331500, AF127228), which have been instrumental for the characterization of proinflammatory effects of MSRV Env [24] and the generation of a monoclonal anti-MSRV/HERV-W Env antibody (6A2B2) [16], are derived from a HERV-W env locus on chromosome Xq22.3. This locus is highly remarkable as it is interrupted by only a single premature stop at codon position 39 and otherwise harbors a long ORF for a N-terminally truncated 475 amino acid HERV-W Env protein (Figure 6). Bonnaud and colleagues described frameshift insertions/deletions (indels), that is, indels whose length is not a multiple of three, in 33 out of 36 analyzed genomic HERV-W env loci. Interestingly, among the three loci without frameshift indels were the ERVWE1 gene and the Xq22.3 HERV-W env element [43]. We further note that the 475 amino acid Xq22.3 HERV-W env ORF is also present in the orthologous locus in chimpanzees (data not shown). These data may be taken as hints that selective pressure could act on the Xq22.3 HERV-W env locus, raising the possibility that Xq22.3 HERV-W env could exert a biological function. Our finding that the Xq22.3 HERV-W env locus is transcriptionally active in human cells indicates that it fulfills at least one essential prerequisite for a protein expression capacity in vivo.
###end p 59
###begin p 60
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 270 274 270 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 661 665 661 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 785 789 785 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 857 866 857 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1126 1130 1126 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1196 1203 1196 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 55 59 <span type="species:ncbi:11827">HERV</span>
###xml 263 267 <span type="species:ncbi:11827">HERV</span>
###xml 303 307 <span type="species:ncbi:11827">HERV</span>
###xml 591 595 <span type="species:ncbi:11827">HERV</span>
###xml 654 658 <span type="species:ncbi:11827">HERV</span>
###xml 778 782 <span type="species:ncbi:11827">HERV</span>
###xml 838 842 <span type="species:ncbi:11827">HERV</span>
###xml 1119 1123 <span type="species:ncbi:11827">HERV</span>
###xml 1280 1284 <span type="species:ncbi:11827">HERV</span>
###xml 1379 1383 <span type="species:ncbi:11827">HERV</span>
Neuropathological studies revealed that the 6A2B2 anti-HERV-W Env antibody reacts with an antigen that is strongly expressed by glial cells in MS brain lesions, but not in normal control brain tissue [18,21,22]. Because Syncytin-1 has been thought to be the only HERV-W env locus capable of producing a HERV-W Env protein, and because 6A2B2 may crossreact with Syncytin-1 [16,43], the antigen detected by 6A2B2 in MS brain lesions was considered to be Syncytin-1. However, our analyses show that the protein against which the 6A2B2 antibody was raised is practically identical to the Xq22.3 HERV-W Env protein (Figure 6) [16]. We meanwhile cloned Xq22.3 HERV-W env into a eukaryotic expression vector. Transient transfection of HeLa cells with this clone showed that the Xq22.3 HERV-W env has retained a coding capacity and can produce a HERV-W Env protein in vitro which is detected by the 6A2B2 antibody in immunocytochemistry and immunoblots (C. Crusius, S. Wahl, K. Ruprecht, manuscript in preparation). These data suggest that the antigen recognized by 6A2B2 in MS lesions could likewise originate from the Xq22.3 HERV-W env locus, provided that this locus has a protein expression capacity in vivo. More elaborate studies will be required to clarify the exact nature of the HERV-W Env protein detected in MS lesions. Further characterization of the putative Xq22.3-encoded HERV-W Env protein, especially in comparison to Syncytin-1, will be necessary for such clarification.
###end p 60
###begin title 61
Conclusion
###end title 61
###begin p 62
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 135 139 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 223 231 223 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 296 300 296 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 304 308 304 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag </italic>
###xml 764 768 764 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 43 47 <span type="species:ncbi:11827">HERV</span>
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 128 132 <span type="species:ncbi:11827">HERV</span>
###xml 411 415 <span type="species:ncbi:11827">HERV</span>
###xml 644 648 <span type="species:ncbi:11827">HERV</span>
###xml 757 761 <span type="species:ncbi:11827">HERV</span>
In conclusion, we demonstrate that several HERV-W env loci are transcribed in human PBMC, and that analysis of such transcribed HERV-W env elements is complicated by frequent recombinations, which are most likely generated in vitro. Based on these findings, we show that previously reported MSRV env and gag sequences can be explained as originating from (in some instances recombined) transcripts of defective HERV-W elements, arguing against MSRV sequences being derived from an infectious exogenous retrovirus. Our results should help to settle the issue of the nature of MSRV and contribute to the clarification of the roles of MSRV versus HERV-W Env (Syncytin-1) in MS. Indeed, our findings raise the intriguing possibility that a protein encoded by a HERV-W env element on chromosome Xq22.3 could be expressed in MS brain lesions.
###end p 62
###begin title 63
Methods
###end title 63
###begin title 64
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients with MS and healthy controls
###end title 64
###begin p 65
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 1108 1110 1108 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 5 13 <span type="species:ncbi:9606">patients</span>
###xml 130 138 <span type="species:ncbi:9606">patients</span>
###xml 213 221 <span type="species:ncbi:9606">patients</span>
###xml 282 290 <span type="species:ncbi:9606">patients</span>
###xml 372 380 <span type="species:ncbi:9606">patients</span>
###xml 417 424 <span type="species:ncbi:9606">patient</span>
###xml 508 516 <span type="species:ncbi:9606">patients</span>
###xml 549 556 <span type="species:ncbi:9606">patient</span>
###xml 602 610 <span type="species:ncbi:9606">patients</span>
###xml 693 701 <span type="species:ncbi:9606">patients</span>
###xml 792 804 <span type="species:ncbi:9606">Participants</span>
Four patients with MS (3 female, 1 male) and 4 healthy controls (2 female, 2 male) were included in this study. The median age of patients was 34 (range 29-39) and of controls 34.5 (29-41) years. Clinical data of patients with MS were obtained by review of the medical records. All patients with MS had a diagnosis of definite MS according to Poser's criteria [56]. Three patients had relapsing-remitting MS, and one patient had secondary progressive MS. The median expanded disability status scale score of patients with MS was 3.25 (1.5-6.5). One patient was treated with interferon-beta 1a, and two patients were treated with glatiramer acetate by the time of blood collection. None of the patients had been treated with glucocorticosteroids for at least 6 months before blood collection. Participants provided written informed consent, and the study was approved by the ethics committee of the faculty of medicine, Julius-Maximilians University, Wurzburg. PBMC samples used in this work were collected and purified with Lymphoprep (Axis Shield, Oslo, Norway) gradient centrifugation as described before [57]. Samples were stored at -80degreesC prior to the present analysis.
###end p 65
###begin title 66
RT-PCR
###end title 66
###begin p 67
###xml 191 193 184 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1212 1216 1186 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1503 1504 1473 1474 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1529 1533 1498 1502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq </italic>
###xml 1205 1209 <span type="species:ncbi:11827">HERV</span>
PBMC were thawed and cultured overnight in RPMI 1640 (BioWhittaker) supplemented with 10% FCS and penicillin (100 U/ml) and streptomycin (100 mug/ml) at 37degreesC in a humidified 5% (v/v) CO2 atmosphere. Total RNA was extracted from PBMC using the RNeasy Mini kit (Qiagen) and eluted in 60 mul of distilled water. RNA concentration and purity were assessed spectrophotometrically. Contaminating DNA was removed using the TURBO DNA-free Kit (Ambion Inc.) following the protocol for rigorous DNAse treatment. In brief, 2 units of TURBO DNase were added to a 50-mul reaction containing 10 mug RNA and incubated for 30 minutes at 37degreesC. Another 2 units of TURBO DNase were added and the incubation was continued for 30 minutes at 37degreesC. DNAse was removed using 10 mul of the provided DNAse inactivation reagent. Subsequently, 0.3-0.5 mug of DNase digested cellular RNA was reverse transcribed in a 20-mul reaction using Superscript II (Invitrogen) and 25 muM random hexamer primers (MWG-Biotech AG) according to the protocol of the manufacturer. Negative controls were generated in parallel for each sample by omission of Superscript II from the reaction. PCR primer sequences for amplification of HERV-W env were as follows: forward primer 5'-TTCACTGCCCACACCCAT-3'; reverse primer 5'-GAGGTACCACAGACAAAAAATATTCCT-3'. Conventional PCR was performed in a 50-mul reaction containing 1 mul of cDNA, 0.5 muM of each primer, 200 muM of each dNTP, reaction buffer (10 mM Tris-HCl, 50 mM KCl, 1.5 mM MgCl2), and 0.05 units/mul of Taq DNA Polymerase (D1806, Sigma). Cycling parameters were as follows: 3 minutes at 95degreesC; 40 cycles of 50 sec at 95degreesC, 50 sec at 58degreesC, and 1 minute at 72degreesC; and 10 minutes at 72degreesC.
###end p 67
###begin title 68
###xml 11 15 <span type="species:ncbi:11827">HERV</span>
###xml 61 65 <span type="species:ncbi:11827">HERV</span>
Cloning of HERV-W env transcripts and assignment to proviral HERV-W loci
###end title 68
###begin p 69
PCR products were excised from agarose gels, purified (NucleoSpin Extract II, Macherey-Nagel), and ligated into the pGEM-T vector (Promega). Plasmid DNA from randomly selected insert-containing clones was purified with the QIAprep Miniprep kit (Qiagen) and sequenced on an Applied Biosystems 3730x Capillary Sequencer using vector-specific primers (Institut fur Immunologie und Genetik, Kaiserlautern, Germany). The quality of chromatograms was assessed by visual inspection. Poor-quality reads (< 0.1% of all sequences) were excluded from the analysis.
###end p 69
###begin p 70
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 163 167 163 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 257 261 257 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 46 50 <span type="species:ncbi:11827">HERV</span>
###xml 156 160 <span type="species:ncbi:11827">HERV</span>
###xml 186 190 <span type="species:ncbi:11827">HERV</span>
###xml 250 254 <span type="species:ncbi:11827">HERV</span>
Assignment of cDNA sequences to corresponding HERV-W env loci is based on random and thus characteristic nucleotide differences between the various genomic HERV-W env loci. The proviral HERV-W env locus with no or very few nucleotide mismatches to a HERV-W env cDNA sequence can be assumed to represent the origin of this cDNA, if all other alternative loci displayed more nucleotide differences. A detailed discussion of the sequence assignment strategy has recently been provided [34].
###end p 70
###begin p 71
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 240 244 240 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 321 325 321 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 459 463 459 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 518 522 518 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 10 14 <span type="species:ncbi:11827">HERV</span>
###xml 45 49 <span type="species:ncbi:11827">HERV</span>
###xml 68 73 <span type="species:ncbi:9606">human</span>
###xml 82 86 <span type="species:ncbi:11827">HERV</span>
###xml 159 164 <span type="species:ncbi:9606">human</span>
###xml 233 237 <span type="species:ncbi:11827">HERV</span>
###xml 252 256 <span type="species:ncbi:11827">HERV</span>
###xml 314 318 <span type="species:ncbi:11827">HERV</span>
###xml 354 359 <span type="species:ncbi:9606">human</span>
###xml 405 410 <span type="species:ncbi:9606">Human</span>
###xml 452 456 <span type="species:ncbi:11827">HERV</span>
###xml 511 515 <span type="species:ncbi:11827">HERV</span>
To assign HERV-W env cDNA clones to specific HERV-W env loci in the human genome, HERV-W env cDNA sequences were first analyzed by BLAT searches (; March 2006 human genome assembly). To further study recombinations between different HERV-W env loci in HERV-W env cDNA sequences, sequences of the seven transcribed HERV-W env loci were retrieved from the human genome sequence (March 2006 assembly) at the Human Genome Browser and multiply aligned with HERV-W env cDNA sequences using Muscle 3.6 [58]. Candidate HERV-W env cDNA sequences were then inspected for recombination events.
###end p 71
###begin title 72
Analysis of MSRV sequences
###end title 72
###begin p 73
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag </italic>
###xml 129 133 <span type="species:ncbi:11827">HERV</span>
###xml 234 238 <span type="species:ncbi:11827">HERV</span>
###xml 409 413 <span type="species:ncbi:11827">HERV</span>
###xml 582 586 <span type="species:ncbi:11827">HERV</span>
###xml 625 629 <span type="species:ncbi:11827">HERV</span>
###xml 667 672 <span type="species:ncbi:9606">Human</span>
Previously published MSRV env and gag sequences were retrieved from GenBank and analyzed by BLAT searches to identify endogenous HERV-W loci with similarities to MSRV sequences. Alignments of the MSRV sequences with the best matching HERV-W locus were manually inspected for evidence of recombination events. In recombined sequence portions, nucleotide mismatches between MSRV sequences and the best matching HERV-W sequence usually clustered in defined subregions. Presumably recombined subregions were used as probe sequences for another BLAT search to detect their best matching HERV-W locus. Sequences of thus identified HERV-W loci were again retrieved from the Human Genome Browser and aligned with the corresponding MSRV sequences.
###end p 73
###begin title 74
Competing interests
###end title 74
###begin p 75
The authors declare that they have no competing interests.
###end p 75
###begin title 76
Authors' contributions
###end title 76
###begin p 77
JM, KR, and NML conceived of the study, participated in its design, and provided funding. GL, BFM, and KR carried out the molecular genetic studies. GL, KR, and JM analyzed the data. KR drafted the manuscript. All authors read and approved the final manuscript.
###end p 77
###begin title 78
Supplementary Material
###end title 78
###begin title 79
Additional file 1
###end title 79
###begin p 80
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sequences of the 332 HERV-W <italic>env </italic>cDNAs analyzed in this study</bold>
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 21 25 <span type="species:ncbi:11827">HERV</span>
###xml 110 114 <span type="species:ncbi:11827">HERV</span>
Sequences of the 332 HERV-W env cDNAs analyzed in this study. This file contains raw sequence data of the 332 HERV-W env cDNAs analyzed in this work.
###end p 80
###begin p 81
Click here for file
###end p 81
###begin title 82
Additional file 2
###end title 82
###begin p 83
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 0 122 0 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Pustell matrix comparisons of the seven HERV-W <italic>env </italic>loci identified as transcriptionally active in human PBMC in this study</bold>
###xml 234 238 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 40 44 <span type="species:ncbi:11827">HERV</span>
###xml 98 103 <span type="species:ncbi:9606">human</span>
###xml 186 190 <span type="species:ncbi:11827">HERV</span>
###xml 227 231 <span type="species:ncbi:11827">HERV</span>
###xml 285 290 <span type="species:ncbi:9606">human</span>
Pustell matrix comparisons of the seven HERV-W env loci identified as transcriptionally active in human PBMC in this study. This file contains Pustell matrix comparisons of the Repbase  HERV-W reference sequence with the seven HERV-W env loci identified as transcriptionally active in human PBMC in this work.
###end p 83
###begin p 84
Click here for file
###end p 84
###begin title 85
Additional file 3
###end title 85
###begin p 86
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag </italic>
###xml 0 110 0 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Alignments of previously published MSRV <italic>env </italic>and <italic>gag </italic>sequences with their corresponding genomic HERV-W elements</bold>
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 189 193 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag </italic>
###xml 95 99 <span type="species:ncbi:11827">HERV</span>
###xml 220 224 <span type="species:ncbi:11827">HERV</span>
Alignments of previously published MSRV env and gag sequences with their corresponding genomic HERV-W elements. This file contains annotated alignments of previously published MSRV env and gag sequences with the genomic HERV-W elements from which the respective MSRV sequences are most likely derived.
###end p 86
###begin p 87
Click here for file
###end p 87
###begin title 88
Acknowledgements
###end title 88
###begin p 89
This study was supported by grants from HOMFOR to KR and JM. JM and NML are furthermore supported by grants from the Deutsche Forschungsgemeinschaft (DFG).
###end p 89
###begin article-title 90
Progress in determining the causes and treatment of multiple sclerosis
###end article-title 90
###begin article-title 91
###xml 24 32 <span type="species:ncbi:9606">patients</span>
Antibodies to HTLV-1 in patients with tropical spastic paraparesis
###end article-title 91
###begin article-title 92
Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles
###end article-title 92
###begin article-title 93
###xml 29 37 <span type="species:ncbi:9606">patients</span>
Isolation of retrovirus from patients with multiple sclerosis
###end article-title 93
###begin article-title 94
###xml 43 50 <span type="species:ncbi:9606">patient</span>
Just another dubious virus in cells from a patient with multiple sclerosis?
###end article-title 94
###begin article-title 95
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis
###end article-title 95
###begin article-title 96
Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles
###end article-title 96
###begin article-title 97
###xml 55 59 <span type="species:ncbi:11827">HERV</span>
###xml 69 96 <span type="species:ncbi:11827">human endogenous retrovirus</span>
Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family
###end article-title 97
###begin article-title 98
###xml 22 27 <span type="species:ncbi:9606">human</span>
Retroelements and the human genome: new perspectives on an old relation
###end article-title 98
###begin article-title 99
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 59 64 <span type="species:ncbi:9606">human</span>
Human endogenous retroviruses: from infectious elements to human genes
###end article-title 99
###begin article-title 100
###xml 25 30 <span type="species:ncbi:9606">human</span>
Processed pseudogenes of human endogenous retroviruses generated by LINEs: their integration, stability, and distribution
###end article-title 100
###begin article-title 101
###xml 20 47 <span type="species:ncbi:11827">human endogenous retrovirus</span>
High copy number in human endogenous retrovirus families is associated with copying mechanisms in addition to reinfection
###end article-title 101
###begin article-title 102
###xml 51 78 <span type="species:ncbi:11827">human endogenous retrovirus</span>
###xml 86 90 <span type="species:ncbi:11827">HERV</span>
Characterization of the intragenomic spread of the human endogenous retrovirus family HERV-W
###end article-title 102
###begin article-title 103
###xml 52 79 <span type="species:ncbi:11827">human endogenous retrovirus</span>
###xml 80 84 <span type="species:ncbi:11827">HERV</span>
Chromosomal distribution and coding capacity of the human endogenous retrovirus HERV-W family
###end article-title 103
###begin article-title 104
###xml 10 15 <span type="species:ncbi:9606">human</span>
Survey of human genes of retroviral origin: identification and transcriptome of the genes with coding capacity for complete envelope proteins
###end article-title 104
###begin article-title 105
###xml 32 59 <span type="species:ncbi:11827">human endogenous retrovirus</span>
###xml 60 64 <span type="species:ncbi:11827">HERV</span>
###xml 87 92 <span type="species:ncbi:9606">human</span>
An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor
###end article-title 105
###begin article-title 106
The endogenous retroviral locus ERVWE1 is a bona fide gene involved in hominoid placental physiology
###end article-title 106
###begin article-title 107
###xml 0 27 <span type="species:ncbi:11827">Human endogenous retrovirus</span>
Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination
###end article-title 107
###begin article-title 108
###xml 25 52 <span type="species:ncbi:11827">human endogenous retrovirus</span>
Quantitative analysis of human endogenous retrovirus-W env in neuroinflammatory diseases
###end article-title 108
###begin article-title 109
###xml 26 53 <span type="species:ncbi:11827">human endogenous retrovirus</span>
Comparative expression of human endogenous retrovirus-W genes in multiple sclerosis
###end article-title 109
###begin article-title 110
###xml 73 81 <span type="species:ncbi:9606">patients</span>
###xml 120 124 <span type="species:ncbi:11827">HERV</span>
###xml 158 177 <span type="species:ncbi:10368">human herpesvirus 6</span>
Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not human herpesvirus 6
###end article-title 110
###begin article-title 111
###xml 4 31 <span type="species:ncbi:11827">human endogenous retrovirus</span>
The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes
###end article-title 111
###begin article-title 112
Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation
###end article-title 112
###begin article-title 113
###xml 26 53 <span type="species:ncbi:11827">human endogenous retrovirus</span>
The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses
###end article-title 113
###begin article-title 114
###xml 158 166 <span type="species:ncbi:9606">patients</span>
Correlation between disease severity and in vitro cytokine production mediated by MSRV (Multiple Sclerosis associated RetroViral element) envelope protein in patients with multiple sclerosis
###end article-title 114
###begin article-title 115
###xml 24 29 <span type="species:ncbi:9606">human</span>
Evolutionary aspects of human endogenous retroviral sequences (HERVs) and disease
###end article-title 115
###begin article-title 116
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 48 53 <span type="species:ncbi:9606">human</span>
Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease
###end article-title 116
###begin article-title 117
MSRV, Syncytin and the role of endogenous retroviral proteins in demyelination
###end article-title 117
###begin article-title 118
###xml 5 9 <span type="species:ncbi:11827">HERV</span>
###xml 94 121 <span type="species:ncbi:11827">human endogenous retrovirus</span>
MSRV/HERV-W/syncytin and its linkage to multiple sclerosis: the usability and the hazard of a human endogenous retrovirus
###end article-title 118
###begin article-title 119
###xml 53 57 <span type="species:ncbi:11827">HERV</span>
###xml 148 153 <span type="species:ncbi:9606">human</span>
The multiple sclerosis-associated retrovirus and its HERV-W endogenous family: a biological interface between virology, genetics, and immunology in human physiology and disease
###end article-title 119
###begin article-title 120
In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: implications for MS pathogenesis
###end article-title 120
###begin article-title 121
###xml 50 54 <span type="species:ncbi:11827">HERV</span>
###xml 67 72 <span type="species:ncbi:9606">human</span>
Particle-associated retroviral RNA and tandem RGH/HERV-W copies on human chromosome 7q: possible components of a 'chain-reaction' triggered by infectious agents in multiple sclerosis?
###end article-title 121
###begin article-title 122
###xml 0 34 <span type="species:ncbi:45617">Human endogenous retrovirus HERV-K</span>
Human endogenous retrovirus HERV-K(HML-2) proviruses with Rec protein coding capacity and transcriptional activity
###end article-title 122
###begin article-title 123
###xml 35 69 <span type="species:ncbi:45617">human endogenous retrovirus HERV-K</span>
###xml 85 90 <span type="species:ncbi:9606">human</span>
###xml 118 122 <span type="species:ncbi:11827">HERV</span>
Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project
###end article-title 123
###begin article-title 124
###xml 0 27 <span type="species:ncbi:11827">Human endogenous retrovirus</span>
###xml 35 41 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 132 137 <span type="species:ncbi:9606">human</span>
Human endogenous retrovirus family HERV-K(HML-2) RNA transcripts are selectively packaged into retroviral particles produced by the human germ cell tumor line Tera-1 and originate mainly from a provirus on chromosome 22q11.21
###end article-title 124
###begin article-title 125
BLAT - the BLAST-like alignment tool
###end article-title 125
###begin article-title 126
Repbase Update, a database of eukaryotic repetitive elements
###end article-title 126
###begin article-title 127
###xml 35 64 <span type="species:ncbi:87786">human endogenous retrovirus W</span>
Transactivation of elements in the human endogenous retrovirus W family by viral infection
###end article-title 127
###begin article-title 128
###xml 19 46 <span type="species:ncbi:11827">human endogenous retrovirus</span>
###xml 81 89 <span type="species:ncbi:9606">patients</span>
Elevated levels of human endogenous retrovirus-W transcripts in blood cells from patients with first episode schizophrenia
###end article-title 128
###begin article-title 129
###xml 62 67 <span type="species:ncbi:9606">human</span>
Identification of endogenous retroviral reading frames in the human genome
###end article-title 129
###begin article-title 130
###xml 43 47 <span type="species:ncbi:11827">HERV</span>
Expression pattern analysis of transcribed HERV sequences is complicated by ex vivo recombination
###end article-title 130
###begin article-title 131
###xml 67 88 <span type="species:ncbi:11786">murine leukemia virus</span>
Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes
###end article-title 131
###begin article-title 132
Evidence of selection on the domesticated ERVWE1 env retroviral element involved in placentation
###end article-title 132
###begin article-title 133
Endogenous retroviruses and cancer
###end article-title 133
###begin article-title 134
###xml 26 53 <span type="species:ncbi:11827">human endogenous retrovirus</span>
###xml 82 87 <span type="species:ncbi:9606">human</span>
Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray
###end article-title 134
###begin article-title 135
###xml 31 36 <span type="species:ncbi:9606">human</span>
Digital expression profiles of human endogenous retroviral families in normal and cancerous tissues
###end article-title 135
###begin article-title 136
###xml 119 122 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
###xml 149 165 <span type="species:ncbi:562">Escherichia coli</span>
Sequence rearrangement and duplication of double stranded fibronectin cDNA probably occurring during cDNA synthesis by AMV reverse transcriptase and Escherichia coli DNA polymerase I
###end article-title 136
###begin article-title 137
Relative rates of retroviral reverse transcriptase template switching during RNA- and DNA-dependent DNA synthesis
###end article-title 137
###begin article-title 138
Template switching by reverse transcriptase during DNA synthesis
###end article-title 138
###begin article-title 139
###xml 79 82 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
Temperature-dependent template switching during in vitro cDNA synthesis by the AMV-reverse transcriptase
###end article-title 139
###begin article-title 140
###xml 27 48 <span type="species:ncbi:11786">murine leukemia virus</span>
Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switching
###end article-title 140
###begin article-title 141
Stimulation and suppression of PCR-mediated recombination
###end article-title 141
###begin article-title 142
DNA recombination during PCR
###end article-title 142
###begin article-title 143
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis
###end article-title 143
###begin article-title 144
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients
###end article-title 144
###begin article-title 145
New diagnostic criteria for multiple sclerosis: guidelines for research protocols
###end article-title 145
###begin article-title 146
###xml 40 58 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls
###end article-title 146
###begin article-title 147
MUSCLE: multiple sequence alignment with high accuracy and high throughput
###end article-title 147

